- Home
- JBLU vs CERT Comparison
JBLU vs CERT Comparison
Compare JBLU & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBLU
- CERT
- Stock Information
- Founded
- JBLU 1998
- CERT 2008
- Country
- JBLU United States
- CERT United States
- Employees
- JBLU N/A
- CERT N/A
- Industry
- JBLU Air Freight/Delivery Services
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- JBLU Consumer Discretionary
- CERT Technology
- Exchange
- JBLU Nasdaq
- CERT Nasdaq
- Market Cap
- JBLU 2.0B
- CERT 1.7B
- IPO Year
- JBLU N/A
- CERT 2020
- Fundamental
- Price
- JBLU $5.08
- CERT $10.52
- Analyst Decision
- JBLU Sell
- CERT Buy
- Analyst Count
- JBLU 11
- CERT 7
- Target Price
- JBLU $5.08
- CERT $15.00
- AVG Volume (30 Days)
- JBLU 18.1M
- CERT 1.2M
- Earning Date
- JBLU 10-28-2025
- CERT 11-05-2025
- Dividend Yield
- JBLU N/A
- CERT N/A
- EPS Growth
- JBLU N/A
- CERT N/A
- EPS
- JBLU N/A
- CERT 0.05
- Revenue
- JBLU $9,138,000,000.00
- CERT $405,755,000.00
- Revenue This Year
- JBLU N/A
- CERT $12.38
- Revenue Next Year
- JBLU $7.48
- CERT $7.49
- P/E Ratio
- JBLU N/A
- CERT $212.55
- Revenue Growth
- JBLU N/A
- CERT 11.61
- 52 Week Low
- JBLU $3.34
- CERT $8.64
- 52 Week High
- JBLU $8.31
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- JBLU 52.01
- CERT 46.10
- Support Level
- JBLU $5.16
- CERT $10.32
- Resistance Level
- JBLU $5.73
- CERT $10.84
- Average True Range (ATR)
- JBLU 0.25
- CERT 0.38
- MACD
- JBLU -0.03
- CERT -0.05
- Stochastic Oscillator
- JBLU 21.69
- CERT 16.26
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.